Published in Hepatitis Weekly, June 28th, 2004
Dr. Richard Stubbs of the Wakefield Gastroenterology Centre in Wellington, New Zealand, presented evidence that treatment with SIR-Spheres (C2616-Brachytherapy-Yttrium 90) - a form of therapeutic radioactive implant used to treat liver cancer - can reduce liver tumors in more than 90% of patients after a single treatment of SIR-Spheres.
"Secondary" liver cancer refers to cancer that has spread to the liver from other locations, often the large bowel and areas affected by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.